Customs Update: China Chemical Import Registration (CIRS) Rule Changes

Overview: MEE Revises Chemical Registration Framework

China’s Ministry of Ecology and Environment (MEE) has implemented significant revisions to the country’s chemical import registration framework, bringing into effect the most comprehensive update to the Measures for the Environmental Management of New Chemical Substances (MEE Order No. 12) since its original promulgation in 2010. The revised framework, which entered into force on January 1, 2025, with a phased compliance transition period running through December 31, 2026, fundamentally changes how foreign chemical manufacturers and importers must register new chemical substances before they can be imported into China.

For companies in the chemical, pharmaceutical, agrochemical, specialty materials, and consumer goods sectors — any business that imports chemical substances into China, whether as finished products, intermediates, or raw materials for manufacturing — understanding the revised CIRS (China Inventory of Existing Chemical Substances) framework is essential for maintaining lawful import operations. Non-compliance carries penalties ranging from import seizure and fines of up to CNY 1 million to criminal liability for environmental damage caused by unregistered substances.

What Changed: The Core Revisions

The revised MEE Order No. 12 introduces changes across five key dimensions of the chemical registration framework. Each change carries specific implications for foreign importers.

1. Expanded Definition of “New Chemical Substance”

Under the previous framework, a “new chemical substance” was defined primarily by its absence from the China Inventory of Existing Chemical Substances — the list of chemical substances that had been registered and were considered “existing” in the Chinese market. The revised framework expands this definition to include substances that, while technically present on the inventory, meet any of the following criteria:

• Purity variance >5%: Substance is listed on the inventory but is being imported at a purity level (including impurity profile) that differs from the registered specification by more than 5 percentage points. This captures refined-grade versus industrial-grade variants of the same base substance.
• Particle size threshold change: Substance is listed but the particle size distribution crosses defined nanotechnology thresholds (d50 < 100nm triggers nano-substance registration requirements, and particles with particle size between 100nm and 500nm that were not previously disclosed require updated notification).
• Different crystal polymorph: Substance is listed but the crystal form (polymorph) being imported was not among those disclosed in the original registration. This change is particularly relevant for pharmaceutical intermediates, where different polymorphs can have significantly different toxicological and environmental fate profiles.
• New use category: Substance is listed for one use category (e.g., industrial intermediate) but is being imported for a different use category (e.g., consumer product ingredient). Different use categories carry different exposure scenarios and risk management requirements under the revised framework.

The expanded definition of “new chemical substance” means that many chemical imports that previously did not require registration under the existing-inventory exemption now require either a full registration or a revised registration notification. The MEE estimates that this expanded scope will bring approximately 8,000-12,000 additional substance-import scenarios within the registration requirement over the first three years of implementation.

2. Tiered Registration System Based on Hazard and Volume

The revised framework replaces the previous notification-based system with a three-tier registration structure that differentiates requirements based on both the substance’s hazard classification and the annual import volume. The tier determines the data requirements, testing protocols, and review timeline.

Tier 1 — General Registration (低量登记): Applies to substances with annual import volume below 1 metric ton and no high-hazard classification. Requires basic physicochemical property data, a simple environmental fate screening, and a one-time notification. Review timeline: 30 working days. Data cost: approximately CNY 50,000-80,000.

Tier 2 — Standard Registration (标准登记): Applies to substances with annual import volume between 1 and 100 metric tons, or any volume for substances classified as hazardous to the aquatic environment (acute category 1 or chronic category 1). Requires full physicochemical property data, acute toxicity data (oral, dermal, inhalation), aquatic toxicity data (acute and chronic for fish, daphnia, algae), and biodegradation screening. Review timeline: 60 working days. Data cost: approximately CNY 200,000-500,000.

Tier 3 — Comprehensive Registration (全面登记): Applies to substances with annual import volume exceeding 100 metric tons, or any volume for substances classified as persistent, bioaccumulative, and toxic (PBT), very persistent and very bioaccumulative (vPvB), carcinogenic, mutagenic, or toxic for reproduction (CMR), or endocrine-disrupting. Requires all Tier 2 data plus chronic toxicity data, reproductive/developmental toxicity screening, environmental fate and transport studies (hydrolysis, photolysis, soil adsorption), and a full chemical safety assessment (CSA) with exposure scenario development. Review timeline: 120 working days. Data cost: approximately CNY 800,000-2,500,000.

The tiered structure aligns China’s framework more closely with the EU’s REACH regulation in terms of the volume-hazard matrix approach, though the specific data requirements and review timelines differ in detail. For foreign importers, the practical implication is the need for early identification of which tier applies to each substance in their import portfolio — an assessment that requires accurate annual volume projections and up-to-date hazard classification data according to the Globally Harmonized System (GHS).

3. Mandatory Third-Party Testing and GLP Certification

A significant process change in the revised framework is the requirement that all toxicological and ecotoxicological testing submitted in support of a CIRS registration must be conducted by a laboratory holding Good Laboratory Practice (GLP) certification recognized by the MEE. Previously, the framework accepted testing data from non-GLP laboratories if the testing protocols were documented and the data were deemed reliable by the reviewing authority.

The MEE has published a list of 47 recognized GLP laboratories, of which 12 are located outside mainland China (in Hong Kong, South Korea, Japan, Germany, the United Kingdom, and the United States). Testing from laboratories not on this list — even if those laboratories hold OECD GLP certification recognized by other regulatory authorities — is not accepted for CIRS registration purposes unless the MEE has entered into a mutual recognition agreement with the laboratory’s home jurisdiction.

This change has created a testing capacity bottleneck, as the 12 international laboratories and 35 domestic laboratories combined have limited throughput capacity for the estimated 2,500-3,500 new registrations expected annually under the revised framework. Current lead times for GLP-compliant testing appointments at the recognized laboratories range from 12 to 26 weeks, depending on the specific test protocol and laboratory availability. Foreign importers are advised to begin the testing process at least six months before they intend to submit the registration application.

The MEE has indicated that it will expand the recognized laboratory list by 15-20 additional laboratories in 2026-2027, but the recognition process is subject to GLP compliance audits and is not expected to materially reduce current lead times before mid-2027.

4. Supply Chain Information Obligations

The revised framework introduces supply chain information obligations that extend the registration requirements beyond the direct importer or registrant. Specifically, the framework now requires that:

• Downstream user notification: The registrant must provide downstream users with a safety data sheet (SDS) that includes the MEE registration number and any risk management measures specified in the registration approval. This mirrors the EU REACH downstream communication obligation.
• Importer chain of responsibility: If a foreign manufacturer engages a China-based importer of record to handle customs clearance, both the foreign manufacturer and the Chinese importer are jointly responsible for ensuring that the CIRS registration requirements are met. Previously, this responsibility was solely on the Chinese importer.
• Exposure scenario disclosure: For Tier 3 registrations, the registrant must develop and disclose exposure scenarios covering the entire lifecycle of the substance — manufacturing (or import), processing, formulation, industrial use, professional use, consumer use, and disposal — and must communicate the relevant exposure scenario to each actor in the supply chain.

For foreign chemical manufacturers, the downstream user notification and exposure scenario obligations require them to either (a) register the substance themselves through a Qualified Authorized Representative (QAR) — analogous to the EU REACH Only Representative model — or (b) work closely with their Chinese importers to ensure that the importers can fulfill the supply chain information obligations. Most foreign manufacturers in the specialty chemicals and fine chemicals sectors are opting for the QAR model, as it gives them more direct control over the registration process and the confidentiality of their substance composition data.

5. Post-Registration Monitoring and Amendment Requirements

The revised framework introduces a post-registration monitoring obligation that did not exist under the previous rules. After a CIRS registration is granted, the registrant must:

1. Annual volume reporting: Submit an annual report to the MEE within 60 days of each registration anniversary, detailing the actual import volume of the registered substance during the preceding year, any changes in the substance’s composition or impurity profile, and any new hazard data that has become available since the original registration.
2. Amendment upon material change: If any of the registration conditions change materially — including a change in the substance’s hazard classification based on new data, a change in the manufacturing process that alters the impurity profile, or an increase in annual import volume that pushes the substance into a higher registration tier — the registrant must file a registration amendment within 90 days of the change becoming known or reasonably foreseeable.
3. Five-year renewal: All CIRS registrations are now subject to a five-year renewal cycle, with a renewal application required no later than six months before the current registration’s expiration date. The renewal application must include updated hazard data (if any new data has become available), updated annual volume data for the preceding five years, and a statement confirming that the substance still warrants the same registration tier as originally granted.

The post-registration monitoring requirements create an ongoing compliance obligation that extends well beyond the initial registration process. Companies with large chemical import portfolios — 50 or more registered substances — should expect to allocate at least one full-time equivalent (FTE) staff member to CIRS post-registration compliance management, including annual report preparation, change monitoring, and renewal application coordination.

Compliance Transition Timeline

The revised framework entered into force on January 1, 2025, but the MEE has established a phased compliance transition period to allow companies to adjust their registration processes without disruption to existing supply chains.

For foreign importers, the critical near-term milestone is December 31, 2026 — the end of the transition period. Any chemical substance that was imported under the previous framework’s existing-inventory exemption but now falls within the expanded definition of “new chemical substance” must be registered by this date. Given the 12-26 week lead time for GLP testing, companies should initiate the registration process for affected substances no later than mid-2026 at the latest — which, practically, means beginning portfolio review and classification assessment now.

Practical Recommendations

Based on the revised framework’s requirements and the transition timeline, foreign chemical importers should take the following actions:

1. Conduct a full portfolio audit against the expanded definition. Review every chemical substance currently imported into China against the revised definition of “new chemical substance” — checking purity variance, particle size, crystal polymorph, and use category against the existing CIRS inventory record. This audit should be completed within 90 days to identify any substances that require new or amended registration before the transition deadline.
2. Determine the applicable registration tier for each substance. For each substance that requires registration, determine which of the three tiers applies based on the actual or projected annual import volume and the substance’s hazard classification. If the hazard classification is not known with sufficient certainty, commission a GHS classification assessment from a qualified toxicology consulting firm.
3. Engage a Qualified Authorized Representative (QAR). Foreign manufacturers without a China-based entity that can serve as the registrant should engage a QAR — a China-based company authorized by the MEE to act as the registration agent for foreign entities. The QAR is legally responsible for the registration application in China, similar to the Only Representative role under EU REACH.
4. Book GLP testing appointments early. Given the 12-26 week lead times for GLP-compliant testing at recognized laboratories, book testing appointments as soon as the portfolio audit identifies which substances require registration. Testing can proceed in parallel with the documentation preparation for the registration application.
5. Implement post-registration compliance processes. Establish internal processes for annual volume tracking, material change monitoring, and renewal calendar management. These processes should be integrated with the company’s existing supply chain management and regulatory compliance systems, not maintained as a separate standalone function.

Where to Go From Here

Based on what you just read:

• Ready to act? Read [guide: SLUG-TO-BE-FILLED]
• Still comparing? See [comparison: SLUG-TO-BE-FILLED]
• Need numbers? Try [tool: SLUG-TO-BE-FILLED]

— China Gateway 360 —
Remote China market entry support, built around execution.